Michael A. Schlesinger - 04 Apr 2022 Form 4 Insider Report for Ortho Clinical Diagnostics Holdings plc

Role: EVP, GC and Secretary
Signature: /s/ Michael A. Schlesinger
Issuer symbol: N/A
Transactions as of: 04 Apr 2022
Net transactions value: -$1,099,331
Form type: 4
Filing time: 06 Apr 2022, 16:05:11 UTC
Previous filing: 05 Jan 2022
Next filing: 01 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCDX	Ordinary Shares, $0.00001 par value	Options Exercise	$552,910	+88,043	+100%	$6.28	175,680	04 Apr 2022	Direct
transaction	OCDX	Ordinary Shares, $0.00001 par value	Sale	$1,652,241	-88,043	-50%	$18.77	87,637	04 Apr 2022	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCDX	Stock Option	Options Exercise	$0	-88,043	-100%	$0.000000^*	0	04 Apr 2022	Ordinary Shares, $0.00001 par value	88,043	$6.28	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
F3	Represents the weighted average sales price for the price increments ranging from $18.6200 to $18.8800.
F4	The stock option is fully vested and exercisable.